Showing 30 of 4116 posts
BSF Enterprise's 3D Bio-Tissues signs a 5-year supply deal with SeaWith. Its City-Mix additive aims to cut cultivated meat growth media costs by ~30%, a strategic commercial win for scaling production.
JoshuaMarch 19, 2026
JPMorgan Global Growth & Income's H1 2025 lags short-term but beats benchmarks over 5 years. Targets 23p dividend, tight discount, and adjusted portfolio.
JoshuaMarch 19, 2026
NAV fell to 35.9p per share, but capital returns of 4.0p have begun. The future value hinges on execution at key assets Dacian Petroleum and Castle View.
JoshuaMarch 19, 2026
US Solar Fund halts dividends, faces wind-up vote at May AGM, and focuses on fixing operational outages to rebuild value.
JoshuaMarch 19, 2026
British Smaller Companies VCT boasts a stellar Q4 with an 8.1x Teraview exit, solid NAV, and hefty cash pile for future bets.
JoshuaMarch 19, 2026
Synthomer confirms resilient 2025 earnings, positive cash flow & no equity raise planned. Focus now on constructive refinancing talks & asset sales to manage 2027 maturities.
JoshuaMarch 19, 2026
Atalaya Mining delivered record 2025 copper production, robust cash flow, a fortified balance sheet, and a fully funded growth pipeline. Strong results support a higher dividend.
JoshuaMarch 19, 2026
British Smaller Companies VCT2's 2025 results: 2.4% NAV return, £15.7m in exits, and 4p dividends paid to shareholders.
JoshuaMarch 19, 2026
Central Asia Metals navigates a $117.8M impairment and 2025 net loss, but holds dividend firm and eyes a resilient 2026 with solid cash generation.
JoshuaMarch 19, 2026
Discover how ENRG's pivot to full asset realisation aims to unlock value with an 8.8% yield and a -35.7% NAV discount.
JoshuaMarch 19, 2026
Sonangol joins Afentra in Angola block acquisition, reshaping partnership strategy with success-based terms and stronger alignment.
JoshuaMarch 19, 2026
Schroder Asian Trust posts a 19.3% share price return in 2025, enters the FTSE 250, but managers adopt a more cautious stance for 2026.
JoshuaMarch 19, 2026
Eco Animal Health beats FY26 forecasts with 8% revenue growth and higher EBITDA, driven by strong performance in North America and Latin America.
JoshuaMarch 19, 2026
Eurocell posts resilient 2025 results with Alunet boosting revenue and profits, strong cash generation, and the appointment of new CEO Will Truman.
JoshuaMarch 19, 2026
DFS reports interim profits doubling, strong cash flow slashing debt, and reinstates its dividend in a robust H1 turnaround.
JoshuaMarch 19, 2026
Record revenue & new buyback as IG launches strategic review to maximise shareholder value.
JoshuaMarch 19, 2026
tinyBuild's FY 2025 turnaround: 17% revenue growth, $5.6m adjusted EBITDA profit, powered by own-IP titles like Hello Neighbor and Deadside.
JoshuaMarch 19, 2026
Capital Limited's 317.6% NPAT surge is driven by investment gains. See the mixed operational results and the 23% revenue growth forecast for 2026.
JoshuaMarch 19, 2026
Energean Israel's 2025 financials show strong profit, but a 2026 production suspension adds risk. Growth projects and refinancing offer key insights.
JoshuaMarch 19, 2026
Halyk Bank's 2025 net income jumps 14.9% on strong lending and fees, though margin pressure and higher credit costs linger.
JoshuaMarch 19, 2026
Aberdeen Asian Income Fund delivers 30% share price return and a 17th consecutive dividend hike, with a new policy targeting a ~6.25% yield from NAV.
JoshuaMarch 18, 2026
Moonpig announces a new £65m share buyback after strong profits and cash generation, with EPS growth expected at the top end of guidance.
JoshuaMarch 18, 2026
Prudential's 2025 results show 12% profit growth, a 15% dividend hike, and plans to return over $7bn to shareholders, powered by robust cash generation.
JoshuaMarch 18, 2026
Supermarket Income REIT upsizes JV loan to £437m at fixed 5.24%, securing funds to refinance near-term debt and extending its financial runway.
JoshuaMarch 18, 2026
Ramsdens upgrades FY26 profit outlook to £24m-£28m, fueled by surging gold prices and growth in pawnbroking and jewellery retail.
JoshuaMarch 18, 2026
Target Healthcare REIT delivered a 6.8% total return in H1 2025, lifted EPRA NTA by 4%, and raised its dividend, fuelled by active capital recycling.
JoshuaMarch 18, 2026
Ruffer Investment Company's interim report reveals a 23% share buyback since August 2023, 4.9% NAV return, and a tight 3.6% discount to NAV.
JoshuaMarch 18, 2026
Mineral & Financial Investments' H1 2026 earnings doubled (+108%) and NAV jumped 29.5%, fueled by precious metals strength and tactical portfolio gains.
JoshuaMarch 18, 2026
Diploma PLC upgrades FY26 guidance: organic growth raised to 9%, operating margin to ~25% & a ~13% profit beat. A classic case of sustainable quality compounding.
JoshuaMarch 18, 2026
Fevara acquires São Paulo production facility to localise high-margin livestock supplements for Brazil's 100m+ cattle market. Strategic expansion targets Q2 production start.
JoshuaMarch 18, 2026